(Q44549275)

4 December 2017

title

IL-18 is produced by prostate cancer cells and secreted in response to interferons (English)

1 reference

4 December 2017

7

1 reference

4 December 2017

Sophie Lebel-Binay

1

1 reference

4 December 2017

Nicolas Thiounn

2

1 reference

4 December 2017

Gonzague De Pinieux

3

1 reference

4 December 2017

Annick Vieillefond

4

1 reference

4 December 2017

Bernard Debré

5

1 reference

4 December 2017

Jean-Yves Bonnefoy

6

1 reference

4 December 2017

Franck Pagès

8

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

International Journal of Cancer

4 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 December 2017

volume

106

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

827-835

1 reference

Cloning of a new cytokine that induces IFN-gamma production by T cells

4 December 2017

cites work

1 reference

Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme

21 January 2018

1 reference

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

21 January 2018

1 reference

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

21 January 2018

1 reference

Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells

21 January 2018

1 reference

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

21 January 2018

1 reference

In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites

21 January 2018

1 reference

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

21 January 2018

1 reference

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

21 January 2018

1 reference

Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression

21 January 2018

1 reference

Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.

21 January 2018

1 reference

IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway

21 January 2018

1 reference

Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression

21 January 2018

1 reference

Enhanced IL-18 expression in common skin tumors

21 January 2018

1 reference

Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells

21 January 2018

1 reference

IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential

21 January 2018

1 reference

Caspases: the executioners of apoptosis

21 January 2018

1 reference

Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells

21 January 2018

1 reference

Control of tumor development by intratumoral cytokines

21 January 2018

1 reference

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

21 January 2018

1 reference

IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis

21 January 2018

1 reference

Enhancement of experimental metastasis by tumor necrosis factor

21 January 2018

1 reference

IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

21 January 2018

1 reference

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

21 January 2018

1 reference

Prognostic Value of Intratumoral Interferon Gamma Messenger RNA Expression in Invasive Cervical Carcinomas

21 January 2018

1 reference

Interleukin‐18 Enhances Lipopolysaccharide‐Induced Interferon‐γ Production in Human Whole Blood Cultures

21 January 2018

1 reference

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

21 January 2018

1 reference

Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance

21 January 2018

1 reference

A comparative analysis of the antigenic, structural, and functional properties of three different preparations of recombinant human interleukin-18

21 January 2018

1 reference

Immunohistochemical study of Fas, Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer.

21 January 2018

1 reference

Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines

21 January 2018

1 reference

MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma

21 January 2018

1 reference

Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies

21 January 2018

1 reference

Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver

21 January 2018

1 reference

Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.11285

1 reference

4 December 2017

1 reference